Results 1 to 10 of about 16,424 (267)

Association of asthma and anti-asthmatic therapy with oral health and microbiota alterations in children - a cross-sectional study [PDF]

open access: yesBMC Pediatrics
Background Asthma and its treatments are recognized as risk factors for oral health in children. The composition of oral microbiota is linked to asthma, as well as to the development of caries and other oral conditions.
Vojko Berce   +4 more
doaj   +2 more sources

Does bronchial asthma influences dental health of the diseased children? [PDF]

open access: yesVojnosanitetski Pregled, 2022
Background/Aim. Asthma is a chronic inflammatory lung disorder. The effect of asthma drugs on oral health is still the subject of debate among researchers in dentistry.
Davidović Bojana   +6 more
doaj   +1 more source

Molecular and immunomodulatory actions of new antiasthmatic agents: Exploring the diversity of biologics in Th2 endotype asthma

open access: yesPharmacological Research, 2022
Asthma is a major respiratory disorder characterised by chronic inflammation and airway remodelling. It affects about 1–8% of the global population and is responsible for over 461,000 deaths annually.
Emmanuel Oshiogwe Okwuofu   +3 more
doaj   +1 more source

Perception of Illness and Fear of Inhaled Corticosteroid Use among Parents of Children with Asthma

open access: yesChildren, 2023
The most prevalent children’s chronic disease worldwide is asthma which has notable negative impacts on patients’ and parent’s quality of life. Daily inhaled corticosteroids (ICS) therapy is a preferred controller choice.
Jasna Petric Duvnjak   +4 more
doaj   +1 more source

Adherence to inhalers and associated factors among adult asthma patients: an outpatient-based study in a tertiary hospital of Rajshahi, Bangladesh

open access: yesAsthma Research and Practice, 2022
Background Adherence to inhaler medication is an important contributor to optimum asthma control along with adequate pharmacotherapy. The objective of the present study was to assess self-reported adherence levels and to identify the potential factors ...
Md. Abdur Rafi   +16 more
doaj   +1 more source

Reslizumab versus placebo for poorly controlled, severe eosinophilic asthma: Meta-analysis [PDF]

open access: yesVojnosanitetski Pregled, 2018
Background/Aim. Reslizumab is humanized monoclonal antibody produced by recombinant DNA technology which binds to circulating interleukin-5 (IL-5) and down-regulates the IL-5 signaling pathway. Reslizumab is indicated for the add-on maintenance treatment
Milosavljević Miloš N.   +5 more
doaj   +1 more source

Short-acting β2-agonist prescriptions in patients with asthma: findings from the South Korean cohort of SABINA III [PDF]

open access: yesThe Korean Journal of Internal Medicine
Background/Aims Despite short-acting β2-agonist (SABA) overuse being associated with poor asthma outcomes, data on SABA use in South Korea is scarce.
Kwang-Ha Yoo   +6 more
doaj   +1 more source

Use of Anti-Asthmatic Medications in Elderly Taiwanese Patients

open access: yesKaohsiung Journal of Medical Sciences, 2003
The aim of this study was to assess the use of anti-asthmatic medications in Taiwanese geriatric asthmatic patients. We used computerized prescription databases from the National Health Insurance Program, Taiwan, and classified drugs according to the ...
Chi-Yu Chen
doaj   +1 more source

Phenanthroindolizidine Alkaloids Secondary Metabolites Diversity in Medicinally Viable Plants of the Genus Tylophora

open access: yesPlants, 2023
Plants of the genus Tylophora have commonly been used in traditional medicine in various communities, especially in the tropical and subtropical regions of climatic zones.
Ehab M. Mostafa   +10 more
doaj   +1 more source

Research on and developmental strategy of anti-asthmatic agents

open access: yesFolia Pharmacologica Japonica, 2008
気管支喘息の基本となる病態が気道の慢性炎症であることから,吸入ステロイド薬を中心とした抗炎症療法の導入は喘息症状のコントロールを可能にし,喘息患者のquality of lifeを飛躍的に向上させた.その一方で,分子レベルでの病態への理解が深まり,特に気道炎症の発症・進展に関わる過程と関連する各種因子の解明が進むことで,より安全で効果的な治療薬の創製に向けた研究開発が試みられている.本稿では,気道炎症の制御を作用メカニズムとした新規喘息治療薬に焦点をあて,その概略を紹介する.
Ryuichi, Totsuka, Matsuo, Kikuchi
openaire   +3 more sources

Home - About - Disclaimer - Privacy